Companies · Healthtech

Usgi Medical Inc

SAN CLEMENTE · Healthtech · refined from filed group “Other Health Care

Diligence memoA one-page analyst read on Usgi Medical Inc — recommendation, valuation, rhythm, risks.
$33.9M
Total raised · real
3
Rounds
0.6×
Latest step-up
Top 15%
Sector rank · raised
Series B
Latest stage · inferred · Mon Feb 25 2019 00:00:00 GMT+0000 (Coordinated Universal Time)

Usgi Medical Inc looks under-valued against its niche peers and is dormant on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the healthtech sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Under-valued
  • Modeled value is 0.13× the median modeled value of Series B Healthtech companies in 2019–2021 (56 peers) — value vs value, same stage and era.
Dormant
  • Last raise 7.3 yr ago; this sector typically re-raises about every 14 months.
  • Silent for over 3× the sector's normal cadence.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Healthtech

Usgi Medical Inc is one of 2138 Healthtech companies tracked from SAN CLEMENTE. By capital raised it ranks in the upper tier (ahead of 86% of sector peers), and mid-pack by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

As reported in public records reported — not modeled.

US
Jurisdiction
Rule 506(b)
Reg D exemption
1
Investors (latest)
2019-02-25
First sale
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$125M$250M$375M$500MSeries B · 2012-05-08 Raised $17M (real) Modeled valuation $410M (est)$17M$410MSeries B2012Series B · 2014-11-04 Raised $15M (real) Modeled valuation $372M (est)$15M$372MSeries B2014Series B · 2019-02-25 Raised $2.4M (real) Modeled valuation $59M (est)$2.4M$59MSeries B2019Seed · 2019-02-25 Raised $1.5M (real) Modeled valuation $42M (est)$1.5M$42MSeed2019+$15M+$2.4M+$1.5MCumulative $35M

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Series B$16.5M · 2012
Series B extension$15.0M · 2014
Series B extension$2.4M · 2019
Bridge · Series B-stage$1.5M · 2019smaller follow-on

Stages are modeled from round size (public records carry no series label). No record for: Pre-Seed, Series A — the company may have raised it under a different exemption, merged it into an adjacent record, or skipped it. Sequence completeness: 50%.

Modeled valuation trajectory
$59.5M
Base estimate est.
$5.6M
Conservative case
$228.9M
Upside case
$13.3M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Series Ba $15M–$40M round). Valuation is modeled from stage benchmarks scaled by the healthtech sector profile. Directional, not a quoted figure.

Series B · modeled $410.1M · 2012-05-082012Series B · modeled $371.8M · 2014-11-04Series B · modeled $59.5M · 2019-02-25Seed · modeled $41.6M · 2019-02-252019
Model inputs · modeled:benchmark-stage-stepup-v1
18%
Dilution assumption
Implied ownership sold in the financing.
64%
Survival probability
42% low · 78% high
1.38×/yr
Annual markup
1.67×/yr upside case
6.0 yr
Elapsed time used
7.3 yr actual, capped for stale marks
healthtech
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
27 mo
Avg between rounds
$5.0M/yr
Capital velocity
14.2 yr
On record since
2012
First round
4
Rounds on file
How it compares to the market

Benchmarked against 2138 companies in Healthtech. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 7.6× above median
This company$33.9M
Sector median$4.5M
Latest round — vs other Series B rounds in sector (real $, this stage) 0.1× of median
This company$1.5M
Sector median$18.3M
Modeled value — vs sector median (estimate, all stages) 1.8× above median
This company$59.5M
Sector median$33.8M

Raised more than 86% of sector peers (real $). Modeled value above 66% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Series B) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #56 of 56.

This companyCohort peer
$10.0M$100.0M$1.0B$10.0B$10.0M$100.0M$1.0BCapital raised (log)Solera Health, Inc. · Series B Raised $79.1M · modeled $935.6M (est)Icebreaker Health, Inc. · Series B Raised $51.5M · modeled $890.1M (est)Buoy Health, Inc. · Series B Raised $66.7M · modeled $837.4M (est)Stroma Medical Corp · Series B Raised $43.0M · modeled $767.6M (est)HealthJoy, Inc. · Series B Raised $45.5M · modeled $743.5M (est)Appriss Health Holdings, Inc. · Series B Raised $38.1M · modeled $718.0M (est)Superconductive Health, Inc. · Series B Raised $61.0M · modeled $717.0M (est)Wheel Health, Inc. · Series B Raised $36.7M · modeled $686.1M (est)Mindoula Health, Inc. · Series B Raised $30.7M · modeled $663.2M (est)Flowonix Medical Inc · Series B Raised $104.6M · modeled $656.8M (est)Sirona Medical, Inc. · Series B Raised $53.0M · modeled $638.3M (est)HealthPlan One Holdings, Inc. · Series B Raised $28.6M · modeled $621.6M (est)Usgi Medical Inc (this company) Raised $33.9M · modeled $59.5M (est)Usgi Medical Inc
CompanyStageRaised · realValue · estvs peer med.
Solera Health, Inc.Series B$79.1M$935.6M2.09×
Icebreaker Health, Inc.Series B$51.5M$890.1M1.99×
Buoy Health, Inc.Series B$66.7M$837.4M1.87×
Stroma Medical CorpSeries B$43.0M$767.6M1.72×
HealthJoy, Inc.Series B$45.5M$743.5M1.66×
Appriss Health Holdings, Inc.Series B$38.1M$718.0M1.61×
Superconductive Health, Inc.Series B$61.0M$717.0M1.60×
Wheel Health, Inc.Series B$36.7M$686.1M1.53×
Mindoula Health, Inc.Series B$30.7M$663.2M1.48×
Flowonix Medical IncSeries B$104.6M$656.8M1.47×
Sirona Medical, Inc.Series B$53.0M$638.3M1.43×
HealthPlan One Holdings, Inc.Series B$28.6M$621.6M1.39×
Usgi Medical Inc this companySeries B$33.9M$59.5M0.13×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Series B$16.5M2012-05-08$91.9M$410.1M85%
Series B$15.0M2014-11-04$83.3M$371.8M85%
Series B$2.4M2019-02-25$13.3M$59.5M90%
Seed$1.5M2019-02-25$7.5M$41.6M90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Series B$16.5M2012-05-08
    • First recorded raise — entered as Series B.
    • 8 investors on this round.
  2. Series B$15.0M2014-11-04
    • Raised again after 30 mo — slower than the ~14 mo sector norm.
    • Round roughly the size of the prior one.
    • Switched to Rule 506(b) (was Rule 06).
    • 2 investors on this round.
  3. Series B$2.4M2019-02-25
    • Raised again after 52 mo — slower than the ~14 mo sector norm.
    • Round 6.3× smaller than the prior — bridge or down round.
    • 1 investor on this round.
  4. Seed$1.5M2019-02-25
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 1.6× smaller than the prior — bridge or down round.
    • 1 investor on this round.
Intelligence
2021 ~Q2
Modeled next raise · ~27mo cadence
$1.5M
Modeled next size est.range $1.5M$2.4M
0.6×
Last step-up
$5.0M/yr
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
Guy Nohra4 other2012-05
Carlos Babini2 other2019-02
John Cox2 other2012-05
Scott Moonly2 other2012-05
William Mavity2 other2012-05
George Abi-Chahine1 other2012-05
Mike Chuisano2014-11
Tracy Maahs2012-05
Registry & provenance

Usgi Medical Inc is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1141772
SEC CIK
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
Luminate Medical Inc.HealthtechSeries B$33.2M$74.1Msame sector · same stage
Optain Health, Inc.HealthtechSeries B$30.7M$59.2Msame sector · same stage
Cecelia Health Holdings, Inc.HealthtechSeries B$37.7M$79.7Msame sector · same stage
Applaud Medical, Inc.HealthtechSeries B$38.0M$44.1Msame sector · same stage
Mantra Health, Inc.HealthtechSeries B$29.1M$53.0Msame sector · same stage
Lexington Wellness Holdings Inc.HealthtechSeries B$41.3M$42.5Msame sector · same stage
Greater Good Healthcare Inc.HealthtechSeries B$41.9M$74.6Msame sector · same stage
Octave Health Group, Inc.HealthtechSeries B$27.4M$38.8Msame sector · same stage
Semantically similar

Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.

CompanySectorStageValue · estMatch
IGI Medical Technologies, LLCHealthtechSeries A$103.8M91%
SIG Medical Corp.HealthtechSeed$55.5M85%
EGA Medical Management LLCHealthtechPre-Seed$6.9M85%
Ryse Health, Inc.HealthtechSeries A$3.4M85%
Welbe Health, LlcHealthtechSeed$83.2M85%
Healthsense IncHealthtechSeries A$65.5M84%
GIE Medical, Inc.HealthtechSeries A$34.0M84%
What About Health, Inc.HealthtechPre-Seed$7.6M84%
Frequently asked
How much funding has Usgi Medical Inc raised?
Usgi Medical Inc has raised approximately $33.9M in disclosed capital across 3 recorded financing rounds, aggregated from public filings.
What is Usgi Medical Inc's estimated valuation?
Provath's modeled valuation for Usgi Medical Inc is approximately $59.5M (modeled range $5.6M–$228.9M). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is Usgi Medical Inc at?
Usgi Medical Inc's latest modeled financing stage is Series B. Its most recent recorded round closed around Mon Feb 25.
What does Usgi Medical Inc do and where is it based?
Usgi Medical Inc operates in the Healthtech sector, based in SAN CLEMENTE.
Explore related

See where Usgi Medical Inc sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at Usgi Medical Inc, claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.